Author

Elisa Landoni

University of North Carolina at Chapel HillORCID 0009-0005-8450-6256Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Gianpietro DottiiD· 2 shared Adriano Venditti· 1 shared Alessio Ottaviani· 1 shared Amy N. CourtneyiD· 1 shared Barbara Savoldo· 1 shared Boning YangiD· 1 shared Carlo Cenciarelli· 1 shared Daniela CerdaiD· 1 shared

Activity by Year

2019-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Gianpietro DottiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintApr 18, 2025

IL-18 metabolically reprograms CAR-expressing natural killer T cells and enhances their antitumor activity against neuroblastoma

Gabriel A. Barragán, Daniela Cerda, Elisa Landoni…·Leonid S. Metelitsa

This study shows that IL-18 enhances antitumor activity of CAR-NKT cells against neuroblastoma by promoting metabolic reprogramming and reducing exhaustion markers.

DOI 10.1101/2025.04.18.649551

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintMar 18, 2019

ELIMINATION OF EGFR-OVEREXPRESSING CANCER CELLS BY CD32 CHIMERIC RECEPTOR T CELLS IN COMBINATION WITH CETUXIMAB OR PANITUMUMAB

Sara Caratelli, Roberto Arriga, Tommaso Sconocchia…·Giuseppe Sconocchia

This study shows CD32131R-CR T cells can eliminate EGFR-overexpressing cancer cells when combined with cetuximab or panitumumab, outperforming CD16158F-CR T cells.

DOI 10.1101/581017

humanproteomics

𝕏 PostBluesky